Skip to main content
European Journal of Translational Myology logoLink to European Journal of Translational Myology
. 2022 Oct 20;32(4):10813. doi: 10.4081/ejtm.2022.10813

Antibiotic use in endodontic treatment during pregnancy: A narrative review

Tahere Aliabadi 1, Eshagh Ali Saberi 1, Amin Motameni Tabatabaie 1,, Ebadolah Tahmasebi 1
PMCID: PMC9830410  PMID: 36268928

Abstract

More than half of pregnant women are usually affected by odontogenic pain affects. Pain often accompanies periapical or pulp infections and increases the risks to pregnant patients and their fetuses. The American Dental Association, in partnership with the American College of Obstetricians and Gynecologists, has offered a strong declaration reaffirming the significance of suitable and timely oral health care as an indispensable constituent of a healthy pregnancy. However, there is lack of knowledge about the use of antibiotics in endodontic treatment. Therefore, the present study would review the researches done in this area and tries to provide comprehensive and complete information about the use of antibiotics in endodontic treatment during pregnancy. Based on the results, it can be said that using antibiotics during pregnancy are allowed, and they can be used normally and safely by pregnant women.

Key Words: Antibiotics, endodontic therapy, pregnancy

Ethical Publication Statement

We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

Oral disease in pregnant women is a major public health issue worldwide.1 Pregnancy does come with inherent risks and the idea that dental treatment should not be implemented due to pregnancy is not debatable. Special concerns are necessary as a pregnant woman seeks dental care;2,3 hence, the treatment related to these patients may need more attention to reduce treatment time and make changes in the type of dental treatment and prescribed drugs.4 Appropriate risk assessment for the mother and fetus should be performed.3According to results of a novel study about pregnant women, it was recognized that more than 43% of them have oral health problems, containing odontogenic infections and pain.5 It is normal that most of odontogenic infections develop quickly to deep-seated infections that ultimately endanger the airway of oropharyngeal.2 Moreover, dental infections usually present with symptoms of pain and swelling in the mouth.6 Misuse of drugs instead of receiving proper dental treatment may consequently lead to damaging effects on the pregnant patient and fetus; so, during pregnancy, it is necessary to notice that odontogenic infections must be treated quickly at any time. One of the suggested treatments is endodontic treatment, which includes cleaning and removing the pulp of a patient's teeth. Root Canal Therapy (RCT) may include radiography, local anesthesia, root cleaning, and intracanal drugs such as analgesics and antibiotics.2 During endodontic treatment, radiography is essential, and to have appropriate diagnosis, proper obstruction, length of work, and assessment after treatment, radiographs are needed. As X-rays during intraoral radiography are directed to the mouth and not the abdomen, it is considered safe for pregnant women. In addition, when performing radiography, a protective method like collimation, high-speed film, lead apron, and filtration is also applied.7 It is recommended that concerned pregnant patients be reassured that the as Low as Reasonably Achievable (ALARA) standard will be used in all circumstances requiring radiographs and that only the necessary radiographs for both treat and diagnosis will be obtained.8 During pregnancy, local anesthesia is considered rather safe if it is managed properly and in the exact amount.9 The overall idea is that sometimes there is a need to administer an increased quantity of anesthesia and that the effects of stress are more dangerous than those of the increased quantity of local anesthesia. Most anesthesia contain vasoconstrictor epinephrine. A maximum dose of 0.1 mg has been added to local anesthesia. No side impacts or abnormalities have been reported, even after the implementation of epidural anesthesia during childbirth.10 Local anesthesia with epinephrine, used as an intravascular injection, has been reported to at least cause a decrease in placental uterine blood flow.9 It has been reported that for healthy pregnant women, a concentration of 1: 100,000 epinephrine applied in dentistry is considered safe accompanied with an appropriate aspiration procedure and limited to the minimum necessary dose.11,12 During pregnancy, RCT is applied to achieve the goals such as preserving a healthy oral environment, controlling the illness, and avoiding possible problems that may happen during the post-childbirth time or in late pregnancy.12 None of the detergents, hypochlorites and root canal fillers used in endodontic are claimed to be harmful to the fetus.2 In addition, some antibiotics and analgesics can be safely prescribed by your dentist as an adjunct to endodontic treatment.13

Management of emergencies and acute disease

In situations such as mild cellulite, drugs like cephalexin, penicillin and amoxicillin, as first-line antibiotics would probably beselected. Also, in the case of allergy to penicillin, Erythromycin or clindamycin (Cleocin) may be applied.The pregnant patient with severe cellulite should be treated at a hospital with an intravenous infusion of clindamycin or cephalosporin. To relive toothache, Acetaminophen can be prescribed. Besides, controlled use of oxycodone and Ibuprofen are proper.14

Some common kinds of dental techniques that can be implemented in each trimester

First trimester: The most vital period for fetal growth. Emergency treatment should be implemented whether or not organogenesis is complete, there are precautions to be made and the patient’s obstetrician should be consulted if organogenesis is incomplete, but emergency treatment is vital. If a pregnant patient experienced a toothache, the dentist can make an emergency opening, eliminate the inflamed pulp (or) drain the pus, and release the pain. Intracanal drugs such as chlorhexidine/metronidazole and calcium hydroxide can be used. In addition, programs containing Plaque diet control for pregnant patient can be initiated.15

Second trimester: During the second trimester of pregnancy, it is the safest phase for treating patients. So, elective and emergency dental treat can be administered in the second trimester. Also, other treatments can be done like periodontal surgery, tooth extraction, and root canal treat.16

Third trimester: If the patient has a toothache, emergency treat can be administered and if possible, transfer definitive treat to the post-childbirth time.17

In 2012, the American Dental Association issued a statement reaffirmed in 2019. It underlines the significance of oral health for pregnant patients at the correct time and in the suitable place. Treatment, the inhibition and control of odontogenic infections as an appropriate treatment is necessary to a healthy pregnancy,18 yet, it has been reported that oral treatments during pregnancy are avoided by numerous dental treat providers.19,20 Evidence for the use of antibiotics as complementary medicine in endodontic treatment is given below.According to the obtained results of some studies in Canada and Netherlands, about 25% to 50% of pregnant women have received antibiotics.21,22 However, it is necessary to prescribe antibiotics to pregnant women after evaluating their disadvantages and advantages.23 It should also be noted that infections can be dangerous for both mother and fetus. For example, one of the risks of spreading infection from the mandibular second molars is the possibility of Ludwig's angina.24,25

Indications for antibiotics in dentistry

According to studies, the use of antibiotics in some cases such as surgery to remove benign tumors, surgery for extraction of impacted teeth, surgery for an implant, bone grafting, and periapical surgery, is prescribed for patients. In treatment of acute infections like invasive localized periodontitis, ulcerative gingivitis, acute apical abscess, periodontal abscess, peri-implantitis, cellulite and pericoronitis, the antibiotics are also suggested.6,26-29

Transport across the placenta

Antibiotics have high fat solubility and low molecular weight. This maintains a high concentration of antibiotics in the blood and facilitates their transfer through the placental barrier. In addition, oral antibiotics are safer than Systemic antibiotics because of their lower absorption.30,31

Classification of antibiotics

The FDA has divided antibiotics into five categories based on their side effects during pregnancy:

Category A: This category includes antibiotics that have been adequately controlled in studies and have not reported any specific side effects during pregnancy.

Category B: Antibiotics have not been observed any specific complications in humans during pregnancy, but side effects have been observed in animals.

Category C: Antibiotics do not have sufficient information about their side effects in pregnant women or animals.

Category D: Antibiotics that have side effects, but they have been proven in pregnancy, but when necessary, their benefits are more than their disadvantages.

Category X: Antibiotics those side effects have been proven in humans and animals and their disadvantages are more than their advantages.32

The next part is a list of the most common antibiotics applied in dentistry during pregnancy.

Penicillin

To treat odontogenic infections, Penicillins are suggested as beta-lactam antibiotics. Amoxicillin, ampicillin (category B), and penicillin VK are suggested as common dental antibiotics. According to the statement of the FDA, no relation has yet been reported linking the implementation of amoxicillin during pregnancy to the miscarriage, the main birth defects, or fetal and maternal side effects. The same results were reported by the Teratogen System Information (TERIS) by examination of 25,000 implementation of penicillin in pregnancy and the increased danger of pregnancy outcomes.18 Nevertheless, there are some evidences that confirm the congenital defects of the oral-maxillofacial complex like cleft lip and palate and hypomineralization in tooth enamel as results of the use of amoxicillin during pregnancy.33-35

As a beta-lactamase inhibitor antibiotic, the combination of amoxicillin and clavulanic acid (co-amoxiclav) is very effective in treating sever odontogenic infections. No evidences have been reported of the relationship between increased dangers of fetal or congenital defects by exposure to therapeutic doses of this combination drug during pregnancy (18). It is worthy to point that the danger of a severe disease called necrotizing enterocolitis in the newborn is increased by use of this drug in the third trimester.36 While the complete danger of infection is not high, this combination drug should be eluded in the third trimester of pregnancy.18

Cephalosporin

They are considered a kind of beta-lactam antibiotics with a broad range. There is no evidence approving an increased danger of spontaneous abortion or miscarriage in pregnant patients used cephalosporins.30 The reports about the relationship between congenital defects in infants and prenatal implementation of cephalosporins are conflicting. Based on results of an examination working on the impacts of cephalosporins in initial use, no adverse effects were reported. It is worthy to mention that some studies approved the relationship between implementation of cephalosporin, anorectal atresia, and atrial septal deficiency in infants.37-39 Yet, the danger of developing abnormalities is not high.

Clindamycin

This drug is frequently applied for patients with a previous hypersensitivity to beta-lactam. There is not enough clinical information on the safety of this category (B). While clindamycin is not associated with outcomes of pregnancy and abortion on the fetus, its use has been associated with congenital cardiovascular and musculoskeletal abnormalities.30,31

Metronidazole

Metronidazole is a very effective category B drug derived from nitroimidazole. The antibiotic metronidazole is prescribed against anaerobic bacteria, usually in combination with penicillin, to treat odontogenic infections. Concerns about the mutagenicity and carcinogenicity of metronidazole have been reported in animal studies; while in human studies the absence of these cases has been confirmed.40,41

There are not same obtained results regarding prenatal metronidazole use and a developed danger of miscarriage.31 No meaningful relationships have been reported between prenatal metronidazole use and fetal deficiencies or adverse pregnancy.26,32,42-50

Tetracycline

Tetracyclines are the same as tetracycline, oxytetracycline, minocycline, and doxycycline. They are all broad-spectrum antibiotics classified in category D.51,52 A study has reported a statistically significant relationship between the use of tetracycline antibiotics and spontaneous abortion of the fetus.31 In addition, the use of tetracyclines has been shown to stain permanent teeth and discolor them.22,53 Therefore, it is recommended that tetracycline be avoided during pregnancy except there is a convincing cause.

Macrolide

Macrolides are similar in antibacterial range to penicillin and usually used for patients with allergy to penicillin. In dentistry, the most frequently used of this group are azithromycin (category B), erythromycin (category B), and clarithromycin (category C)..

Based on the new findings, macrolide use has not been related to cardiovascular defects in newborns and the previous beliefs were rejected.54-56 According to gained results of a novel meta-analysis, an increased danger of cerebral palsy-epilepsy, miscarriage, and gastrointestinal abnormalities were reported as the results of macrolide use during pregnancy.57 Based on another finding, acetate macrolides are not relatively safer than basic form of erythromycin.58

Table 1.

Management of antibiotics for pregnant patients in dentistry.

Acceptable drugs Food and Drug Unacceptable Food and Drug
during pregnancy Administration drugs during Administration
Category pregnancy Category
Penicillin B Tetracyclines D
Amoxicillin B Erythromycin D
Cephalosporins B (estolate form)
Antibiotics Clindamycin B Quinolones C
Erythromycin (except for estolate form) B Clarithromycin C

Fluoroquinolones

They are broad-range category C antibiotics with restricted usage. For odontogenic infections, they are just applied for patients with allergy to penicillins or treatment of bacteria unaffected by other antibiotics. Meanwhile, their implementation for odontogenic infections in endodontics is restricted. Meta-analysis findings have not been able to reveal the use of fluoroquinolones, especially ciprofloxacin, that upsurge the danger of preterm delivery, miscarriage, and fetal abnormalities.59,60

Table 1. shows management of antibiotics for pregnant patients in dentistry.

Benefits and harms of antibiotics

Most pregnant women are prescribed to use a variety of medicines. The drugs may have teratogenic influences on the fetus during pregnancy. In addition, drugs used during breastfeeding can have severe effects on the health of the baby. During pregnancy and lactation, one of the most used drugs is antibiotics frequently prescribed by doctors.42

Infections and Preterm labor

According to the definition of The World Health Organization, preterm labor is labor that happens at more than 20 weeks and less than 37 weeks gestation.43 The frequency of preterm labor in developed countries differs between 7 and 11%.44,45 In the last 40 years, in spite of all progresses in midwifery care, the danger of prematurity has not reduced.46 In developed countries, prematurity is recognized as one of the main reasons of mortality and neonatal morbidity and it is the cause of 60% to 80% of neonatal mortality deprived of congenital abnormalities. Despite the low percentage of births less than 32 weeks' gestation (only 1% to 2% of all births), they are reason for 50% of long-term neurological problems as well as 60% of prenatal deaths.43,47 Pointing to the financial issues, preterm labor is remarkably significant as one-tenth of the cost of general child care and one-third of the cost of caring for infants is related to preterm labor.48,61During the two past decades, many kinds of investigations have underlined the reasons of preterm labor and consequently various correlated risk elements have been recognized.62 Most common reported ones are congenital causes of infectious origin.63-65 The possible associations between preterm labor and infection can be explained by models that claim that preterm labor is initiated by an inflammatory reaction to pro-inflammatory cytokines such as IL-6, IL-8, interleukin (IL) -1 beta, and TNF-alpha.66 Based on the evidences from clinical and laboratory examinations, there is a relationship between labor and systemic infections and spontaneous preterm labor.63,67 As a result, it is widely an accepted logical assumption that antibiotics play an effective role in the handling of preterm labor.68,69 Although the relationship between inflammation and infection with the increased danger of preterm labor is crucial, yet it is not identified whether antibiotic handling can inhibit it. Moreover, it is believed that antibiotic treatment to inhibit preterm labor can be dangerous.67,70-71

Side effects of misuse of antibiotics

Antibiotic resistance is a natural phenomenon, but it can be caused by the misuse of antibiotics.72 The plans to inhibit his misuse of antibiotics can have consequent worldwide results for inhibiting the expansion of antibiotic-resistant bacterial strains.26 There is some data that antibiotic implementation can lead to severe side effects such as gastrointestinal abnormalities, allergic reactions, and cardiac arrhythmias, and death73 The expansion of resistant bacteria is recognized as a main problematic issue linked to the overuse of antibiotics.74,75 It is claimed that the use of antibiotics during fetal-neonatal life has an opposing and long-term influence on the maternal intestinal microbiota and the maternal vaginal microbiota. Furthermore, it can lead to the expansion of allergic illnesses. Antibiotics may also inhibit and delay with the beginning colonization of the baby's gut microbiota.76 This inhibition may restrict the development and growth of the baby's immune system, causing diseases and allergies.77,78 Overuse of antibiotics for pregnant women is linked to the presence of many antibiotic-resistant organisms, as the rate of erythromycin-resistant Streptococcus (Group B) -one of the selective antibiotics after premature rupture of membranes (PROM) prescribed in most British hospitals- and reaches 35%.79-81

In conclusion, according to the results of researches, aspecifically evidences published by the American Dental Association with American Obstetricians, the use of some antibiotics during pregnancy are allowed and can be used normally and safely by pregnant women.

Acknowledgments

None

List of acronyms

ALARA

as Low as Reasonably Achievable

FDA

U.S. Food and drugs administration

IL

interleukin

PROM

premature rupture of membranes

RCT

Root Canal Therapy

TERIS

Teratogen System Information

Funding Statement

Funding None

Contributor Information

Tahere Aliabadi, Email: tbkh457@yahoo.com.

Eshagh Ali Saberi, Email: saberiendo@zaums.ac.ir.

Ebadolah Tahmasebi, Email: ba.ahmed89@yahoo.com.

References

  • 1.Geevarghese A, Baskaradoss JK, Sarma PS. Oral Health-Related Quality of Life and Periodontal Status of Pregnant Women. Matern Child Health J. 2017. Aug;21(8):1634-1642. doi: 10.1007/s10995-016-2255-y.. [DOI] [PubMed] [Google Scholar]
  • 2.Ibhawoh L, Enabulele J. Endodontic treatment of the pregnant patient: Knowledge, attitude and practices of dental residents. Niger Med J. 2015. Sep-Oct;56(5):311-6. doi: 10.4103/0300-1652.170386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cengiz SB. The pregnant patient: considerations for dental management and drug use. Quintessence Int. 2007. Mar;38(3):e133-42. [PubMed] [Google Scholar]
  • 4.Buttino L. Principles & practice of medical therapy in pregnancy: McGraw-Hill Medical Publishing; 1998; 1998. [Google Scholar]
  • 5.Hashim R. Self-reported oral health, oral hygiene habits and dental service utilization among pregnant women in United Arab Emirates. Int J Dent Hyg. 2012. May;10(2):142-6. doi: 10.1111/j.1601-5037.2011.00531.x. Epub 2011 Oct 31.. [DOI] [PubMed] [Google Scholar]
  • 6.Koyuncuoglu CZ, Aydin M, Kirmizi NI, Aydin V, Aksoy M, Isli F, Akici A. Rational use of medicine in dentistry: do dentists prescribe antibiotics in appropriate indications? Eur J Clin Pharmacol. 2017. Aug;73(8):1027-1032. doi: 10.1007/s00228-017-2258-7. Epub 2017 May 1. [DOI] [PubMed] [Google Scholar]
  • 7.Richards AG, Colquitt WN. Reduction in dental X-ray exposures during the past 60 years. J Am Dent Assoc. 1981. Nov;103(5):713-8. doi: 10.14219/jada.archive.1981.0378. [DOI] [PubMed] [Google Scholar]
  • 8.Gibbs RS, Karlan BY, Haney AF, Nygaard IE. Danforth's obstetrics and gynecology: Lippincott Williams & Wilkins Philadelphia, PA, USA; 2008. [Google Scholar]
  • 9.Giglio JA, Lanni SM, Laskin DM, Giglio NW. Oral health care for the pregnant patient. J Can Dent Assoc. 2009. Feb;75(1):43-8. [PubMed] [Google Scholar]
  • 10.Gurbet A, Turker G, Kose DO, Uckunkaya N. Intrathecal epinephrine in combined spinal-epidural analgesia for labor: dose-response relationship for epinephrine added to a local anesthetic-opioid combination. Int J Obstet Anesth. 2005. Apr;14(2):121-5. doi: 10.1016/j.ijoa.2004.12.002 [DOI] [PubMed] [Google Scholar]
  • 11.Enabulele J, Ibhawoh L. Resident obstetricians' awareness of the oral health component in management of nausea and vomiting in pregnancy. BMC Pregnancy Childbirth. 2014. Nov 25;14:388. doi: 10.1186/s12884-014-0388-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Little JW, Falace D, Miller C, Rhodus NL. Dental Management of the Medically Compromised Patient-Pageburst on VitalSource: Elsevier Health Sciences; 2007. [Google Scholar]
  • 13.Khan SA, Hassan AU, Iqbal Z, Hassan MJJ. Endodontic Management of Acute Dental Pain Among Pregnant Patients. JPDA. 2021;30(01). [Google Scholar]
  • 14.Silk H, Douglass AB, Douglass JM, Silk L. Oral health during pregnancy. Am Fam Physician. 2008. Apr 15;77(8):1139-44. [PubMed] [Google Scholar]
  • 15.Koletzko B, Cremer M, Flothkötter M, Graf C, Hauner H, Hellmers C, Kersting M, Krawinkel M, Przyrembel H, Röbl-Mathieu M, Schiffner U, Vetter K, Weißenborn A, Wöckel A. Diet and Lifestyle Before and During Pregnancy - Practical Recommendations of the Germany-wide Healthy Start - Young Family Network. Geburtshilfe Frauenheilkd. 2018. Dec;78(12):1262-1282. doi: 10.1055/a-0713-1058. Epub 2018 Sep 25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sant'Ana AC, Campos MR, Passanezi SC, Rezende ML, Greghi SL, Passanezi E. Periodontal treatment during pregnancy decreases the rate of adverse pregnancy outcome: a controlled clinical trial. J Appl Oral Sci. 2011. Apr;19(2):130-6. doi: 10.1590/s1678-77572011000200009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wasylko L, Matsui D, Dykxhoorn SM, Rieder MJ, Weinberg S. A review of common dental treatments during pregnancy: implications for patients and dental personnel. J Can Dent Assoc. 1998. Jun;64(6):434-918. [PubMed] [Google Scholar]
  • 18.Ather A, Zhong S, Rosenbaum AJ, Quinonez RB, Khan AA. Pharmacotherapy during Pregnancy: An Endodontic Perspective. J Endod. 2020. Sep;46(9):1185-1194. doi: 10.1016/j.joen.2020.05. 024. [DOI] [PubMed] [Google Scholar]
  • 19.George A, Shamim S, Johnson M, Dahlen H, Ajwani S, Bhole S, Yeo AE. How do dental and prenatal care practitioners perceive dental care during pregnancy? Current evidence and implications. Birth. 2012. Sep;39(3):238-47. doi: 10.1111/j.1523-536X.2012.00553.x. Epub 2012 Jun 27. [DOI] [PubMed] [Google Scholar]
  • 20.Marchi KS, Fisher-Owens SA, Weintraub JA, Yu Z, Braveman PA. Most pregnant women in California do not receive dental care: findings from a population-based study. Public Health Rep. 2010. Nov-Dec;125(6):831-42. doi: 10.1177/ 003335491012500610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Santos F, Oraichi D, Bérard A. Prevalence and predictors of anti-infective use during pregnancy. Pharmacoepidemiol Drug Saf. 2010. Apr;19(4):418-27. doi: 10.1002/pds.1915. [DOI] [PubMed] [Google Scholar]
  • 22.de Jonge L, Bos HJ, van Langen IM, de Jong-van den Berg LT, Bakker MK. Antibiotics prescribed before, during and after pregnancy in the Netherlands: a drug utilization study. Pharmacoepidemiol Drug Saf. 2014. Jan;23(1):60-8. doi: 10.1002/pds.3492. Epub 2013 Aug 3. [DOI] [PubMed] [Google Scholar]
  • 23.Machowska A, Sihavong A, Eriksen J, Vongsouvath M, Marrone G, Sychareun V, Hanson C, Keohavong B, Brauner A, Mayxay M, Kounnavong S, Lundborg CS. Containment of Antibiotic REsistance-measures to improve antibiotic use in pregnancy, childbirth and young children (CAREChild): a protocol of a prospective, quasiexperimental interventional study in Lao PDR. BMJ Open. 2020. Nov 19;10(11):e040334. doi: 10.1136/bmjopen-2020-040334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Romero R, Gómez R, Chaiworapongsa T, Conoscenti G, Kim JC, Kim YM. The role of infection in preterm labour and delivery. Paediatr Perinat Epidemiol. 2001. Jul;15 Suppl 2:41-56. doi: 10.1046/j.1365-3016.2001.00007.x. [DOI] [PubMed] [Google Scholar]
  • 25.Osunde O, Bassey G, Ver-Or N. Management of Ludwig's Angina in Pregnancy: A Review of 10 Cases. Ann Med Health Sci Res. 2014. May;4(3):361-4. doi: 10.4103/2141-9248.133460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Oberoi SS, Dhingra C, Sharma G, Sardana D. Antibiotics in dental practice: how justified are we. Int Dent J. 2015. Feb;65(1):4-10. doi: 10.1111/idj.12146. Epub 2014 Dec 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ahmadi H, Ebrahimi A, Ahmadi F. Antibiotic Therapy in Dentistry. Int J Dent. 2021. Jan 28;2021:6667624. doi: 10.1155/2021/6667624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Lodi G, Azzi L, Varoni EM, Pentenero M, Del Fabbro M, Carrassi A, Sardella A, Manfredi M. Antibiotics to prevent complications following tooth extractions. Cochrane Database Syst Rev. 2021. Feb 24;2(2):CD003811. doi: 10.1002/14651858.CD003811.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hussein RJ, Krohn R, Kaufmann-Kolle P, Willms G. Quality indicators for the use of systemic antibiotics in dentistry. Z Evid Fortbild Qual Gesundhwes. 2017. May;122:1-8. doi: 10.1016/j.zefq.2017.04.007. Epub 2017 May 16. [DOI] [PubMed] [Google Scholar]
  • 30.Muanda FT, Sheehy O, Bérard A. Use of antibiotics during pregnancy and risk of spontaneous abortion. CMAJ. 2017. May 1;189(17):E625-E633. doi: 10.1503/cmaj.161020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Muanda FT, Sheehy O, Bérard A. Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study. Br J Clin Pharmacol. 2017. Nov;83(11):2557-2571. doi: 10.1111/bcp.13364. Epub 2017 Aug 11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sá del Fiol F, Gerenutti M, Groppo FC. Antibiotics and pregnancy. Pharmazie. 2005. Jul;60(7):483-93. [PubMed] [Google Scholar]
  • 33.Lin KJ, Mitchell AA, Yau WP, Louik C, Hernández-Díaz S. Maternal exposure to amoxicillin and the risk of oral clefts. Epidemiology. 2012. Sep;23(5):699-705. doi: 10.1097/EDE.0b013e318258cb05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Puhó EH, Szunyogh M, Métneki J, Czeizel AE. Drug treatment during pregnancy and isolated orofacial clefts in hungary. Cleft Palate Craniofac J. 2007. Mar;44(2):194-202. doi: 10.1597/05-208.1. [DOI] [PubMed] [Google Scholar]
  • 35.Gottberg B, Berné J, Quiñónez B, Solórzano E. Prenatal effects by exposing to amoxicillin on dental enamel in Wistar rats. Med Oral Patol Oral Cir Bucal. 2014. Jan 1;19(1):e38-43. doi: 10.4317/medoral.18807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2003;(2):CD001058. doi: 10.1002/14651858.CD001058. Update in: Cochrane Database Syst Rev. 2010;(8):CD001058. [DOI] [PubMed] [Google Scholar]
  • 37.Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: a population-based, case-control study. Am J Obstet Gynecol. 2001. May;184(6):1289-96. doi: 10.1067/mob.2001.113905. [DOI] [PubMed] [Google Scholar]
  • 38.Ailes EC, Gilboa SM, Gill SK, Broussard CS, Crider KS, Berry RJ, Carter TC, Hobbs CA, Interrante JD, Reefhuis J; and The National Birth Defects Prevention Study. Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011. Birth Defects Res A Clin Mol Teratol. 2016. Nov;106(11):940-949. doi: 10.1002/bdra.23570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med. 2009. Nov;163(11):978-85. doi: 10.1001/archpediatrics.2009.188. [DOI] [PubMed] [Google Scholar]
  • 40.Dobiás L, Cerná M, Rössner P, Srám R. Genotoxicity and carcinogenicity of metronidazole. Mutat Res. 1994. Jun;317(3):177-94. [PubMed] [Google Scholar]
  • 41.Rustia M, Shubik P. Experimental induction of hepatomas, mammary tumors, and other tumors with metronidazole in noninbred Sas:MRC(WI)BR rats. J Natl Cancer Inst. 1979. Sep;63(3):863-8. doi: 10.1093/jnci/63.3.863. [DOI] [PubMed] [Google Scholar]
  • 42.Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol. 2006. May;107(5):1120-38. doi: 10.1097/01.AOG. 0000216197.26783.b5. [DOI] [PubMed] [Google Scholar]
  • 43.Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008. Jan 5;371(9606):75-84. doi: 10.1016/S0140-6736(08)60074-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Marcos Z. Arriving too early. Lancet Neurol. 2013. Apr;12(4):332-3. doi: 10.1016/S1474-4422(13)70041-3. Epub 2013 Feb 21. [DOI] [PubMed] [Google Scholar]
  • 45.Lawn JE, Kinney MV, Belizan JM, Mason EM, McDougall L, Larson J, Lackritz E, Friberg IK, Howson CP; Born Too Soon Preterm Birth Action Group. Born too soon: accelerating actions for prevention and care of 15 million newborns born too soon. Reprod Health. 2013;10 Suppl 1(Suppl 1):S6. doi: 10.1186/1742-4755-10-S1-S6. Epub 2013 Nov 15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Chang HH, Larson J, Blencowe H, Spong CY, Howson CP, Cairns-Smith S, Lackritz EM, Lee SK, Mason E, Serazin AC, Walani S, Simpson JL, Lawn JE; Born Too Soon preterm prevention analysis group. Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet. 2013. Jan 19;381(9862):223-34. doi: 10.1016/S0140-6736(12)61856-X. Epub 2012 Nov 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol. 2003. Jan;101(1):178-93. doi: 10.1016/s0029-7844(02)02366-9. [DOI] [PubMed] [Google Scholar]
  • 48.Soilly AL, Lejeune C, Quantin C, Bejean S, Gouyon JB. Economic analysis of the costs associated with prematurity from a literature review. Public Health. 2014. Jan;128(1):43-62. doi: 10.1016/j.puhe.2013.09.014. Epub 2013 Dec 18. [DOI] [PubMed] [Google Scholar]
  • 49.Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol. 1995. Feb;172(2 Pt 1):525-9. doi: 10.1016/0002-9378(95)90567-7. [DOI] [PubMed] [Google Scholar]
  • 50.Koss CA, Baras DC, Lane SD, Aubry R, Marcus M, Markowitz LE, Koumans EH. Investigation of metronidazole use during pregnancy and adverse birth outcomes. Antimicrob Agents Chemother. 2012. Sep;56(9):4800-5. doi: 10.1128/AAC.06477-11. Epub 2012 Jul 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Cohlan SQ. Tetracycline staining of teeth. Teratology. 1977. Feb;15(1):127-9. doi: 10.1002/tera.1420150117. [DOI] [PubMed] [Google Scholar]
  • 52.Cohlan SQ, Bevelander G, Tiamsic T. Growth inhibition of prematures receiving tetracycline: a clinical and laboratory investigation of tetracycline-induced bone fluorescence. Am J Dis Child. 1963;105(5):453-461. doi:10.1001/archpedi .1963.02080040455005 [Google Scholar]
  • 53.Wormser GP, Wormser RP, Strle F, Myers R, Cunha BA. How safe is doxycycline for young children or for pregnant or breastfeeding women? Diagn Microbiol Infect Dis. 2019. Mar;93(3):238-242. doi: 10.1016/j.diagmicrobio.2018.09.015. [DOI] [PubMed] [Google Scholar]
  • 54.Romøren M, Lindbæk M, Nordeng H. Pregnancy outcome after gestational exposure to erythromycin - a population-based register study from Norway. Br J Clin Pharmacol. 2012. Dec;74(6):1053-62. doi: 10.1111/j.1365-2125.2012.04286.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Lin KJ, Mitchell AA, Yau WP, Louik C, Hernández-Díaz S. Safety of macrolides during pregnancy. Am J Obstet Gynecol. 2013. Mar;208(3):221.e1-8. doi: 10.1016/j.ajog.2012.12.023. Epub 2012 Dec 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Lin KJ, Mitchell AA, Yau WP, Louik C, Hernández-Díaz S. Safety of macrolides during pregnancy. Am J Obstet Gynecol. 2013. Mar;208(3):221.e1-8. doi: 10.1016/j.ajog.2012.12. 023. Epub 2012 Dec 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.McCormack WM, George H, Donner A, Kodgis LF, Alpert S, Lowe EW, Kass EH. Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrob Agents Chemother. 1977. Nov;12(5):630-5. doi: 10.1128/AAC.12.5.630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.McCormack WM, George H, Donner A, Kodgis LF, Alpert S, Lowe EW, Kass EH. Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrob Agents Chemother. 1977. Nov;12(5):630-5. doi: 10.1128/AAC.12.5.630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Ziv A, Masarwa R, Perlman A, Ziv D, Matok I. Pregnancy Outcomes Following Exposure to Quinolone Antibiotics - a Systematic-Review and Meta-Analysis. Pharm Res. 2018. Mar 26;35(5):109. doi: 10.1007/s11095-018-2383-8. [DOI] [PubMed] [Google Scholar]
  • 60.Acar S, Keskin-Arslan E, Erol-Coskun H, Kaya-Temiz T, Kaplan YC. Pregnancy outcomes following quinolone and fluoroquinolone exposure during pregnancy: A systematic review and meta-analysis. Reprod Toxicol. 2019. Apr;85:65-74. doi: 10.1016/j.reprotox.2019.02.002. Epub 2019 Feb 7. [DOI] [PubMed] [Google Scholar]
  • 61.Gilbert WM, Nesbitt TS, Danielsen B. The cost of prematurity: quantification by gestational age and birth weight. Obstet Gynecol. 2003. Sep;102(3):488-92. doi: 10.1016/s0029-7844(03)00617-3. [DOI] [PubMed] [Google Scholar]
  • 62.Takayama JI, Matsuo N. The enigma of spontaneous preterm birth. N Engl J Med. 2010. May 27;362(21):2032-3; author reply 2033-4. [PubMed] [Google Scholar]
  • 63.Pararas MV, Skevaki CL, Kafetzis DA. Preterm birth due to maternal infection: Causative pathogens and modes of prevention. Eur J Clin Microbiol Infect Dis. 2006. Sep;25(9):562-9. doi: 10.1007/s10096-006-0190-3. [DOI] [PubMed] [Google Scholar]
  • 64.Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, Turner M, McCormack A, Lapidus JA, Hitti J, Eschenbach DA, Roberts CT Jr, Nagalla SR. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA. 2004. Jul 28;292(4):462-9. doi: 10.1001/jama.292.4.462. Erratum in: JAMA. 2004 Nov;292(19): 2340. [DOI] [PubMed] [Google Scholar]
  • 65.Burdet J, Rubio AP, Salazar AI, Ribeiro ML, Ibarra C, Franchi AM. Inflammation, infection and preterm birth. Curr Pharm Des. 2014;20(29):4741-8. doi: 10.2174/1381612820666140130202224. [DOI] [PubMed] [Google Scholar]
  • 66.Martinez de Tejada B. Antibiotic use and misuse during pregnancy and delivery: benefits and risks. Int J Environ Res Public Health. 2014. Aug 7;11(8):7993-8009. doi: 10.3390/ijerph110807993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Lamont RF, Nhan-Chang CL, Sobel JD, Workowski K, Conde-Agudelo A, Romero R. Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011. Sep;205(3):177-90. doi: 10.1016/j.ajog.2011.03. 047. Epub 2011 Apr 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Kenyon SL, Taylor DJ, Tarnow-Mordi W; ORACLE Collaborative Group. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group. Lancet. 2001. Mar 31;357(9261):989-94. doi: 10.1016/s0140-6736(00)04234-3. [DOI] [PubMed] [Google Scholar]
  • 69.King J, Flenady V. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev. 2002;(4):CD000246. doi: 10.1002/14651858.CD000246. Update in: Cochrane Database Syst Rev. 2013;12: CD000246. [DOI] [PubMed] [Google Scholar]
  • 70.Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, Taylor DJ. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet. 2008. Oct 11;372(9646):1319-27. doi: 10.1016/S0140-6736(08)61203-9. Epub 2008 Sep 17. [DOI] [PubMed] [Google Scholar]
  • 71.Mercer BM, Goldenberg RL, Das AF, Thurnau GR, Bendon RW, Miodovnik M, Ramsey RD, Rabello YA; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What we have learned regarding antibiotic therapy for the reduction of infant morbidity after preterm premature rupture of the membranes. Semin Perinatol. 2003. Jun;27(3):217-30. doi: 10.1016/s0146-0005(03)00016-8. [DOI] [PubMed] [Google Scholar]
  • 72.Acar J, Davies J, Buckley M. Antibiotic resistance: an ecological perspective on an old problem. 2009. doi: 10.1128/AAMCol.12Oct.2008 [Google Scholar]
  • 73.Rao GA, Mann JR, Shoaibi A, Bennett CL, Nahhas G, Sutton SS, Jacob S, Strayer SM. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death. Ann Fam Med. 2014. Mar-Apr;12(2):121-7. doi: 10.1370/afm.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Morales WJ, Dickey SS, Bornick P, Lim DV. Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. Am J Obstet Gynecol. 1999. Aug;181(2):310-4. doi: 10.1016/s0002-9378(99)70553-3. [DOI] [PubMed] [Google Scholar]
  • 75.Heelan JS, Hasenbein ME, McAdam AJ. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol. 2004. Mar;42(3):1263-4. doi: 10.1128/JCM.42.3.1263-1264.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Fetissov SO, Déchelotte P. The new link between gut-brain axis and neuropsychiatric disorders. Curr Opin Clin Nutr Metab Care. 2011. Sep;14(5):477-82. doi: 10.1097/MCO.0b013e32834936e7. [DOI] [PubMed] [Google Scholar]
  • 77.Bedford Russell AR, Murch SH. Could peripartum antibiotics have delayed health consequences for the infant? BJOG. 2006. Jul;113(7):758-65. doi: 10.1111/j.1471-0528.2006.00952.x. [DOI] [PubMed] [Google Scholar]
  • 78.Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics. 2008. Apr;121(4):689-96. doi: 10.1542/peds.2007-2171. [DOI] [PubMed] [Google Scholar]
  • 79.Tan S, Holliman R, Russell AR. Hazards of widespread use of erythromycin for preterm prelabour rupture of membranes. Lancet. 2003. Feb 1;361(9355):437. doi: 10.1016/s0140-6736(03)12420-8. [DOI] [PubMed] [Google Scholar]
  • 80.Gygax SE, Schuyler JA, Trama JP, Mordechai E, Adelson ME. Detection of erythromycin and clindamycin resistance genes in Group B Streptococcal clinical isolates and cervicovaginal-rectal swabs. Microb Drug Resist. 2007. Summer;13(2):119-23. doi: 10.1089/mdr.2007.732. [DOI] [PubMed] [Google Scholar]
  • 81.Yadav NR, Jain M, Monga A, Sharma A. Management of Pregnant patient in a Dental Clinical Setting. Annals of the Romanian Society for Cell Biology, 2021;25(6):18728–18736. Retrieved from https://www.annalsofrscb.ro/index.php/journal/article/view/9403. [Google Scholar]

Articles from European Journal of Translational Myology are provided here courtesy of PAGEPress

RESOURCES